The Nobel winner count for July's International Congress of Genetics has risen to eight, with confirmation that Sir John Sulston will be joining fellow 2002 Medicine laureates Sir Sydney Brenner and Prof Robert Horvitz in Melbourne. [ + ]

Severe burns, like those experienced by Bali bombing victims, could be healed in half the time due to world-first research by QUT and the Red Cross. The International Red Cross Society Bali Relief Fund has provided more than $300,000 for the research project which aims to speed the rate at which a skin graft grows both in the laboratory and on a patient's body.

US company Cephalon has made a $AUD271 million takeover offer for Sydney-based cancer treatment company Sirtex Medical. [ + ]

The Geoffrey Gardiner Dairy Foundation has announced the inaugural recipients of its major research and development funding initiative. [ + ]

CSIRO structural biologist Jose Varghese believes that synchrotrons are essential tools for finding out how proteins work, and designing drugs to specifically interact with them. [ + ]

A Melbourne workshop organised by the Australian Synchrotron Project last week attracted 350 participants, including representatives from synchrotrons all over the world. [ + ]

Despite slightly lower than expected revenues for the half-year ending December 31, Adelaide company GroPep was on track for full recovery, said CFO Tony Mitchell today. [ + ]

Researchers hunting the serial murderer responsible for the progressive, mass-death of neurons in Alzheimer's disease, the most common form of dementia, have found a new suspect. [ + ]

The global oil and gas industry will benefit from the establishment of a world-class energy technology research alliance signed recently in Western Australia.

The first fruits of anti-cancer drug developer Peplin Biotech's landmark licensing deal with US pharmaceutical company Allergan have surfaced in the form of a 240 per cent surge in Peplin's first-half revenues. [ + ]

Biosensor company Ambri has learned first-hand the fickle nature of the share market -- a stock slide that saw the company lose almost a third of its value since mid-December, before recovering 22 per cent on Friday, was precipitated by a single shareholder selling off its entire holding in the company. [ + ]

Getting a suitably challenging position is a bigger concern to many returning expatriate Australians than salary, attendees heard at the first BioMelbourne Breakfast for this year. [ + ]

The story of the so-called prion diseases, including 'mad cow' disease, is one of the strangest in the annals of 20th century medical science -- and it grows stranger still. [ + ]

Melbourne diagnostics company Cellestis has received a major boost with the release of the US Centre for Disease Control and Prevention (CDC) guidelines for its Quantiferon-TB diagnostic test for tuberculosis (TB). [ + ]

A new branch of genetics is being born. It might legitimately be called junk science, but Prof John Mattick has dubbed it 'Rnomics'... and it's the stuff of revolution. [ + ]